Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 12/2008

01-12-2008 | Brief Report

Group A streptococcal infection caused by emm1 strains among children in southern Taiwan

Authors: H.-C. Lin, S.-M. Wang, Y.-L. Lin, Y.-S. Lin, J.-J. Wu, W.-J. Chuang, M. T. Lin, C.-C. Liu

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 12/2008

Login to get access

Abstract

The aim of this study was to characterize the molecular epidemiology of invasive and non-invasive group A streptococcus (GAS) infections in children from 1997 through 2004 in southern Taiwan. A collection of 32 invasive and 150 non-invasive isolates were recruited for analysis. emm1 (34.4%) and emm12 (40.0%) predominated in the invasive and non-invasive isolates, respectively. The peak incidence of invasive GAS infection (IGASI) occurred between 2002 and 2003. emm4 and emm12 were the major types among clinical isolates before 2001, and was replaced by emm1 during 2002–2003. All emm1 isolates were clonal relatedness. The declined prevalence of erythromycin resistance occurred in the major shift of the endemic isolates to emm1 strains during 2002–2003 in the community.
Literature
1.
go back to reference Holm SE, Norrby A, Bergholm AM et al (1992) Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988–1989. J Infect Dis 166:31–37PubMed Holm SE, Norrby A, Bergholm AM et al (1992) Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988–1989. J Infect Dis 166:31–37PubMed
2.
go back to reference Kiska DL, Thiede B, Caracciolo J et al (1997) Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 176:992–1000PubMedCrossRef Kiska DL, Thiede B, Caracciolo J et al (1997) Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 176:992–1000PubMedCrossRef
3.
go back to reference Ruoff KL, Whiley RA, Beighton D (2003) Streptococcus. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology, 8th edn. ASM Press, Washington, DC, pp 405–421 Ruoff KL, Whiley RA, Beighton D (2003) Streptococcus. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology, 8th edn. ASM Press, Washington, DC, pp 405–421
6.
go back to reference Clinical and Laboratory Standards Institute (CLSI) (2006) Performance standards for antimicrobial susceptibility testing; 16th informational supplement, vol. 26, no. 3. M100-S16. CLSI, Wayne, PA Clinical and Laboratory Standards Institute (CLSI) (2006) Performance standards for antimicrobial susceptibility testing; 16th informational supplement, vol. 26, no. 3. M100-S16. CLSI, Wayne, PA
7.
8.
go back to reference Hsueh PR, Shyr JM, Wu JJ (2005) Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan. Clin Infect Dis 40:903–905. doi:10.1086/427946 PubMedCrossRef Hsueh PR, Shyr JM, Wu JJ (2005) Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan. Clin Infect Dis 40:903–905. doi:10.​1086/​427946 PubMedCrossRef
10.
go back to reference Rogers S, Commons R, Danchin MH et al (2007) Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. J Infect Dis 195:1625–1633. doi:10.1086/513875 PubMedCrossRef Rogers S, Commons R, Danchin MH et al (2007) Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. J Infect Dis 195:1625–1633. doi:10.​1086/​513875 PubMedCrossRef
Metadata
Title
Group A streptococcal infection caused by emm1 strains among children in southern Taiwan
Authors
H.-C. Lin
S.-M. Wang
Y.-L. Lin
Y.-S. Lin
J.-J. Wu
W.-J. Chuang
M. T. Lin
C.-C. Liu
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 12/2008
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0561-z

Other articles of this Issue 12/2008

European Journal of Clinical Microbiology & Infectious Diseases 12/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.